Skip links

Clinical Trials and Studies

Clinical research trial to evaluate the safety and efficacy of a novel drug called SAR443122, a RIPK1-inhibitor, in patients with moderate to severe CLE

LMC Manna Research are conducting a clinical research trial at their Manna London location (230 Victoria St., Suite 225, London, ON  N6A 2C2) regarding new treatments for CLE. They are looking for patients who have moderate to severe cutaneous lupus erythematosus (CLE). The purpose of this study is to learn about the effects of a new drug called SAR443122.  For more information on this clinical trial please email Thahmina at thahmina.rahman@lmcmanna.com or visit https://lmcmannaresearch.com/therapeutic-areas/dermatology-study/#!/study/233

Seeking transplant recipients or other immunosuppressed people and their family members for a study on the impact of COVID-19

Researchers from the Canadation Donation and Transplantation Research Program along with the CHUM Research Center in Montréal are conducting a national study on the impact of the COVID-19 pandemic on immunosuppressed people and their relatives.

For more information, please visit: https://cdtrp.ca/en/seeking-for-transplant-recipients-other-immunosuppressed-people-and-their-family-members-for-a-study-on-the-impact-of-covid-19/

Return to top of page